Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 21 Sept 2026 for Bolt Biotherapeutics, Inc., €4,636. Read the official filing
Filing timeline
BuySaleGrant Yonehiro
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Grant Yonehiro: trading record in brief
Grant Yonehiro discloses dealings in Bolt Biotherapeutics, Inc. to SEC (Form 4). The record holds 4 filings, for trades running from 22 October 2025 to 18 September 2026.
Sales make up the whole of the open-market record (3 sales, €38k). Outside the open market, there are 1 share grant. In 2026 alone, the filings show no purchases and 3 sales.
The record was last updated on 21 September 2026 with an open-market sale (€14k) in Bolt Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Grant Yonehiro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,417 shares@ US$3.774Common StockSEC:0001193125-26-396894:0
4,909 shares@ US$3.3183Common StockSEC:0001193125-26-396894:1
6,850 shares@ US$3.2364Common StockSEC:0001193125-26-396894:2
30,000 shares0Common StockSEC:0001193125-25-250333:0
4 of 4 declarations
